Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 14
Submit an article Journal homepage
218
Views
29
CrossRef citations to date
0
Altmetric
Review

Expert opinion on available options treating pulmonary arterial hypertension

Robert Naeije Professor and Chairman, Erasme University Hospital, Department of Pathophysiology, Erasme Campus, CP 604, 808, Lennik Road, B-1070 Brussels , Belgium +322 5553322; +322 5554124; [email protected]; Consultant, Erasme University Hospital, Department of Cardiology
&
Sandrine Huez Assistant, Erasme University Hospital, Department of Cardiology
, MD
Pages 2247-2265 | Published online: 10 Oct 2007

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ralf Ewert, Christoph Schäper, Michael Halank, Sven Gläser & Christian F Opitz. (2009) Inhalative iloprost – pharmacology and clinical application. Expert Opinion on Pharmacotherapy 10:13, pages 2195-2207.
Read now
Michael J Palmer. (2009) Leads for the treatment of pulmonary hypertension. Expert Opinion on Therapeutic Patents 19:5, pages 575-592.
Read now

Articles from other publishers (27)

Mario Boehm, Ralph Theo Schermuly & Baktybek Kojonazarov. 2021. The Right Heart. The Right Heart 27 52 .
Deependra Singh, Arun KS Parihar, Satish Patel, Shikha Srivastava, Prakriti Diwan & Manju R Singh. (2019) Scleroderma: An insight into causes, pathogenesis and treatment strategies. Pathophysiology 26:2, pages 103-114.
Crossref
Mathew J. Platt, Jason S. Huber, Nadya Romanova, Keith R. Brunt & Jeremy A. Simpson. (2018) Pathophysiological Mapping of Experimental Heart Failure: Left and Right Ventricular Remodeling in Transverse Aortic Constriction Is Temporally, Kinetically and Structurally Distinct. Frontiers in Physiology 9.
Crossref
Didier Renard, Thomas Bouillon, Ping Zhou, Gerard Flesch & Debbie Quinn. (2015) Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension. British Journal of Clinical Pharmacology 80:1, pages 75-85.
Crossref
Priska Kaufmann, Kaori Okubo, Shirin Bruderer, Tim Mant, Tetsuhiro Yamada, Jasper Dingemanse & Hideya Mukai. (2015) Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag. American Journal of Cardiovascular Drugs 15:3, pages 195-203.
Crossref
Wiebke Janssen, Ralph Theo Schermuly & Baktybek Kojonazarov. 2014. The Right Heart. The Right Heart 45 67 .
Baktybek Kojonazarov, Akylbek Sydykov, Soni Savai Pullamsetti, Himal Luitel, Bhola K. Dahal, Djuro Kosanovic, Xia Tian, Matthaeus Majewski, Christin Baumann, Steve Evans, Peter Phillips, David Fairman, Neil Davie, Chris Wayman, Iain Kilty, Norbert Weissmann, Friedrich Grimminger, Werner Seeger, Hossein Ardeschir Ghofrani & Ralph Theo Schermuly. (2013) Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling. International Journal of Cardiology 167:6, pages 2630-2637.
Crossref
Ali A. Weinstein, Lisa M.K. Chin, Randall E. Keyser, Michelle Kennedy, Steven D. Nathan, Joshua G. Woolstenhulme, Gerilynn Connors & Leighton Chan. (2013) Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension. Respiratory Medicine 107:5, pages 778-784.
Crossref
Laurent B. Nicolas, Marcelo M. Gutierrez & Jasper Dingemanse. (2013) Comparative Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Profiles of 3 Different Formulations of Epoprostenol Sodium for Injection in Healthy Men. Clinical Therapeutics 35:4, pages 440-449.
Crossref
Sy Duong-Quy, Yihua Bei, Zhongmin Liu & Anh Tuan Dinh-Xuan. (2013) Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacology & Therapeutics 137:3, pages 352-364.
Crossref
Dioma U. Udeoji & Ernst R. Schwarz. (2012) Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Therapeutic Advances in Respiratory Disease 7:1, pages 39-49.
Crossref
Laurent B. Nicolas, Andreas Krause, Marcelo M. Gutierrez & Jasper Dingemanse. (2012) Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects. British Journal of Clinical Pharmacology 74:6, pages 978-989.
Crossref
Eri Ogawa, Tomohide Hori, Hiraku Doi, Hajime Segawa & Shinji Uemoto. (2011) Living‐donor liver transplantation for moderate or severe porto‐pulmonary hypertension accompanied by pulmonary arterial hypertension: a single‐centre experience over 2 decades in Japan. Journal of Hepato-Biliary-Pancreatic Sciences 19:6, pages 638-649.
Crossref
Robin M. Fowler, Kevin R. Gain & Eli Gabbay. (2012) Exercise Intolerance in Pulmonary Arterial Hypertension. Pulmonary Medicine 2012, pages 1-10.
Crossref
Juan C. Roig, James Fink & David J. Burchfield. 2011. Assisted Ventilation of the Neonate. Assisted Ventilation of the Neonate 347 370 .
Michael Ramsay. (2010) Portopulmonary hypertension and right heart failure in patients with cirrhosis. Current Opinion in Anaesthesiology 23:2, pages 145-150.
Crossref
Hossein-Ardeschir GhofraniRobert VoswinckelHenning GallRalph SchermulyNorbert WeissmannWerner SeegerFriedrich Grimminger. (2010) Riociguat for pulmonary hypertension. Future Cardiology 6:2, pages 155-166.
Crossref
Mantej K ChhinaWeir NarguesGeraldine M GrantSteven D Nathan. (2010) Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension. Future Cardiology 6:1, pages 19-35.
Crossref
J. Günther, K. Schulte, D. Wenzel, B. Malinowska & E. Schlicker. (2009) Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266. Naunyn-Schmiedeberg's Archives of Pharmacology 381:1, pages 21-31.
Crossref
George Dranitsaris & Sanjay Mehta. (2012) Oral therapies for the treatment of pulmonary arterial hypertension. Applied Health Economics and Health Policy 7:1, pages 43-59.
Crossref
Bing Cui, Yu-Si Cheng, De-Zai Dai, Na Li, Tian-Tai Zhang & Yin Dai. (2009) CPU0213, A NON-SELECTIVE ET A /ET B RECEPTOR ANTAGONIST, IMPROVES PULMONARY ARTERIOLAR REMODELING OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN RATS . Clinical and Experimental Pharmacology and Physiology 36:2, pages 169-175.
Crossref
H Kozłowska, M Baranowska, E Schlicker, M Kozłowski, J Laudañski & B Malinowska. (2008) Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. British Journal of Pharmacology 155:7, pages 1034-1042.
Crossref
Gökhan Tunçbilek, Petek Korkusuz & Figen Özgür. (2008) Effects of Iloprost on Calvarial Sutures. Journal of Craniofacial Surgery 19:6, pages 1472-1480.
Crossref
O. Kowal-Bielecka, M. Delcroix, A. Vonk-Noordegraaf, M. M. Hoeper & R. Naeije. (2008) Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis. Rheumatology 47:Supplement 5, pages v39-v41.
Crossref
C. Lafaras, E. Mandala, E. Verrou, D. Platogiannis, N. Barbetakis, T. Bischiniotis & K. Zervas. (2008) Non-thromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot study. Annals of Oncology 19:10, pages 1765-1769.
Crossref
Noriaki Emoto, Naohito Matsuo, Takayuki Ohnishi, Kazuya Miyagawa, Hiroki Kato, Naoko Iwasa, Akihiro Yoshida, Hiroya Kawai, Ken-ichi Hirata & Yuichi Kuroda. (2008) Remarkable Response of Bosentan, an Endothelin Receptor Antagonist, for a Patient with Eisenmenger Syndromeエンドセリン受容体拮抗薬が著効した心房中隔欠損症に伴うEisenmenger症候群の1例. Nihon Naika Gakkai Zasshi 97:10, pages 2549-2551.
Crossref
Katherine F Croom & Monique P Curran. (2008) Sildenafil. Drugs 68:3, pages 383-397.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.